Laparoscopic helium plasma coagulation for the treatment of endometriosis

National Institute for Health and Clinical Excellence
Record ID 32006000717
English
Authors' objectives:

This study aims to assess the current evidence on laparoscopic helium plasma coagulation for the treatment of endometriosis. This document replaces previous guidance on laparoscopic helium plasma coagulation of endometriosis (NICE interventional procedure guidance no. 54).

Authors' recommendations: 1 Guidance 1.1 Current evidence suggests there are no major safety concerns associated with laparoscopic helium plasma coagulation for the treatment of endometriosis. However, evidence on efficacy does not appear adequate for this procedure to be used without special arrangements for consent and for audit or research. 1.2 Clinicians wishing to undertake laparoscopic helium plasma coagulation for the treatment of endometriosis should take the following actions. - Inform the clinical governance leads in their Trusts. - Ensure that patients understand the uncertainty about the efficacy of the procedure and provide them with clear written information. In addition, use of the Institute's Information for the public is recommended (available from www.nice.org.uk/IPG171publicinfo). - Audit and review clinical outcomes of all women undergoing laparoscopic helium plasma coagulation for the treatment of endometriosis. 1.3 Clinicians undertaking this procedure should have adequate training before performing the technique. The British Society for Gynaecological Endoscopy has produced standards for training (www.bsge.net). 1.4 Publication of randomised controlled trials on the efficacy of this procedure will be useful. The Institute may review the procedure upon publication of further evidence.
Authors' methods: Overview
Details
Project Status: Completed
Year Published: 2006
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England
MeSH Terms
  • Electrocoagulation
  • Laparoscopy
  • Endometriosis
  • Helium
Contact
Organisation Name: National Institute for Health and Care Excellence
Contact Address: Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name: nice@nice.nhs.uk
Contact Email: nice@nice.nhs.uk
Copyright: National Institute for Health and Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.